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Background: Ectopic crypts, defined as abnormally positioned crypts that have lost their orientation toward the
muscularis mucosae, have been suggested to be the best defining histologic feature of traditional serrated
adenoma (TSA). However, the significance of ectopic crypt formation (ECF) in the distinction between TSA and
conventional adenoma (CA) has rarely been studied.
Methods: We designed this study to determine if ECF can be found in CA and its presence is exclusive to TSA.
We studied 107 TSAs and 191 CAs including 106 tubular adenomas (TAs), 66 tubulovillous adenomas (TVAs),
and 19 villous adenomas (VAs).
Results: ECF was identified in most (79.4%) but not all TSAs. Additionally, ECF was not infrequent in CA (62
of 191, 32.5%), and its presence correlated with the presence of a villous component and larger tumor size
(each p <0.001).
Conclusions: Based on its strong association with the presence of a villous component and larger tumor size,
ECF appears to be involved in the protuberant growth of colorectal CA. Because ECF can be found in CA,
particularly in cases with a villous component, the possibility of CA should be considered before making a
diagnosis of TSA when encountering colorectal polyps with ECF.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.
diagnomx.eu/vs/13000_2014_212
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The term traditional serrated adenoma (TSA) refers to a
distinct subtype of serrated polyps and was initially pro-
posed for polyps showing a mixture of hyperplastic and
adenomatous features [1]. The original definition of TSA
referred to a lesion characterized by its overall protuber-
ant exophytic configuration, complex villous growth pat-
tern, and tall columnar cells with abundant eosinophilic
cytoplasm and elongated pencillate nuclei [1-3].
Recently, the presence of ectopic crypt formation (ECF),
defined as development of abnormally positioned crypts
that have lost their orientation toward the muscularis mu-
cosae, was suggested to be the best defining histologic fea-
ture to diagnose TSAs based on the report of Torlakovic* Correspondence: mjkimdoc@gmail.com
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unless otherwise stated.et al. that the presence of ECF was almost exclusive to
TSAs among serrated polyps and was observed in all TSA
cases [4,5]. However, the diagnostic reliability of ECF in
the diagnosis of colorectal polyps, particularly in the dis-
tinction of TSAs from other much more common polyps
such as conventional adenoma (CA), has rarely been stud-
ied [3]. We performed this study to determine whether
ECF can be present in CA and whether its presence is a
pathognomonic feature in the diagnosis of TSA.Methods
Study sample and histologic evaluation
The present study included 107 TSA samples from 104
patients, all of which were retrieved from the Department
of Pathology of Daehang Hospital in Seoul, Korea, be-
tween November 2011 and September 2012, as previously
described [6]. Of 104 patients, three patients had two
TSAs in different location. The lesions were obtained by. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Detectable mutations using the MassArray
method (ASAN Panel)
Gene Type Exon Mutation











BRAF Point Exon 15 V600E
Kim et al. Diagnostic Pathology 2014, 9:212 Page 2 of 8
http://www.diagnosticpathology.org/content/9/1/212polypectomy, endoscopic mucosal resection (EMR), endo-
scopic submucosal dissection (ESD), or transanal excision.
Consultation or referral cases from other hospitals were
not included in the study. We also studied 191 consecu-
tive CA samples obtained from 188 patients, including
106 tubular adenomas (TAs), 66 tubulovillous adenomas
(TVAs), and 19 villous adenomas (VAs), which were
completely removed by endoscopic ESD (n = 182) or
EMR (n = 9) between January 2011 and September 2012.
Among 188 patients with CA, three of them had syn-
chronous CA in different location and underwent ESD for
both lesions. None of the CA cases were obtained from
patients with TSA. All TSA and CA samples were entirely
submitted irrespective of size in order to allow evaluation
of histopathologic features without any missing areas.
ECF was defined as abnormal development of crypts
with loss of orientation toward the muscularis mucosae
[4]. In brief, based on previously published histologic cri-
teria, TSA was characterized by a serrated architecture
and at least a focal area containing tall columnar cells
with elongated nuclei and abundant eosinophilic cyto-
plasm [2]. We also investigated features of conventional
epithelial dysplasia such as extensive nuclear crowding,
nuclear enlargement, loss of nuclear polarity, pseudos-
tratification extending to the upper half of the neo-
plastic cell, and increased mitoses, according to criteria of
previously published studies [7,8]. The size and loca-
tion of polyps were recorded. The sizes of the polyps
were obtained from the pathologist’s measurements. The
anatomical sites of polyps were identified and classified as
proximal colon (up to the splenic flexure) versus distal
colon/rectum.
CA was defined as an adenomatous polyp arranged
in a tubular and/or villous architecture. Cytologic dysplasia
characterized by the presence of cells with nuclear enlarge-
ment, elongation, hyperchromasia, pseudostratification, in-
creased mitoses, and crowding was diffusely identified in
the polyp in a top-down manner. The degree of dysplasia
was determined according to the WHO classification cri-
teria [3]. CAs were subdivided into TA, TVA, and VA ac-
cording to the percentage of villous component (<25%,
25-75%, >75%, respectively) [3].
Patients with familial adenomatous polyposis, heredi-
tary nonpolyposis colorectal cancer syndrome, or inflam-
matory bowel disease were excluded from this study.
Patients were assessed for clinicopathologic features,
including age and sex, anatomic site and size of the
polyp, and the presence and type of synchronous or
metachronous sessile serrated adenoma/polyp (SSA/P)
upon follow-up by reviewing the patients’ medical records
and endoscopy and pathology reports. The slides were
stained with hematoxylin and eosin. Tissue collection was
approved by the Institutional Review Board at Daehang
Hospital.DNA extraction
A total of 107 TSA cases containing an adequate amount
of tissue in the paraffin blocks were used for molecular
studies. In brief, five sections of 10 μm thickness samples
were used for genomic DNA extraction. Genomic DNA
was extracted using the QIAamp DNA formalin-fixed
paraffin-embedded (FFPE) tissue kit (#56404; Qiagen,
Hilden, Germany) according to the manufacturer’s instruc-
tions. In three CAs with significant numbers of ectopic
crypts, we also performed microdissection. Microdissec-
tion was performed with great caution using the marked
slide as a guide. A razor blade was used to scrape off the
cells of interest into a 1.5 ml microcentrifuge tube.
Detection of mutations for KRAS and BRAF genes using
MassArray technology
As previously described, mutation detection was car-
ried out using an ASAN Panel under the Sequenom
MassArray technology platform with the iPLEX-Pro
chemistry (Sequenom, San Diego, USA) following the
manufacturer’s instructions with minor modifications [6].
In brief, specific assay pools (ASAN Panel) were designed
using Assay Designer software in the MassArray Typer
package (v4.0). The list of genes and mutations assessed
by Sequenom are presented in Table 1. After multiplex
PCR with the following program; 95°C for 15 min; 45 cy-
cles of incubations at 95°C for 20 sec, 56°C for 30 sec,
72°C for 30 sec; a final 72°C for 3 min, PCR-amplified
DNA was cleansed using a shrimp alkaline phosphatase
(SAP) mixture from the iPLEX-Prokit (Cat# 10142-2,
Sequenom), and primer was extended by the iPLEX chem-
istry, desalted using a cation exchange resin (Sequenom)
and spotted onto SpectroCHIP II matrix chips using a
MassArray nanodispenser. Mass determination was done
with the MassArray Analyzer Compact MALDI-TOF
mass spectrometer. The MassArray Typer 4.0 software
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were called after cluster analysis using the default setting
of a Gaussian mixture model. Genotype calls were then
further reviewed manually to undo any uncertain calls due
to clustering artifact. Mutations for a subset of samples
and targets were confirmed by Sanger sequencing [6].
Direct DNA sequencing for KRAS and BRAF
Direct DNA sequencing was performed to verify mutations
in KRAS and BRAF. Polymerase chain reaction (PCR)
amplification was performed according to the previ-
ously published condition [6,10]. The amplified DNA
products were then purified using Montage centrifugal fil-
ters (Millipore, Bedford, MA). After purification, direct
sequencing was carried out using an ABI PRISM 310 se-
quence analyzer (Applied Biosystem, Foster city, CA).
Statistical analysis
Analysis of data was done using SPSS version 21.0 (SPSS
Inc., Chicago, IL, USA). For comparing parametric dis-
tributions, a Student t-test was used, and for frequency
distributions, a χ2 test or Fisher exact test was used. A
p value <0.05 was considered statistically significant.
Results
Patient demographics and tumor characteristics
A total of 107 TSA cases were obtained from 104 patients
comprising 55 males and 49 females with a mean age of
61.2 years. The majority (74.8%) of polyps occurred in the












Proximal 27 (25.2%) 62 (58.5%)
Distal 80 (74.8%) 44 (41.5%)
Mean tumor size (cm) 1.3 2.7
Procedure
Polypectomy 37 (34.6%) 0
EMR 57 (53.3%) 5 (4.7%)
ESD 12 (11.2%) 101 (95.3%)
Transanal excision 1 (0.9%) 0
TSA, traditional serrated adenoma; CA, conventional adenoma; TA, tubular adenom
endoscopic mucosal resection; ESD, endoscopic submucosal dissection.
a107 TSAs from 104 patients.
b191 CAs from 188 patients.(25.2%) of cases were obtained from the proximal colon.
The sizes of the polyps ranged from 0.3 cm to 5.2 cm, with
a mean size of 1.3 cm. The size of the lesion differed sig-
nificantly according to the status of conventional epithelial
dysplasia, which was noted in 23 TSA lesions (21.5%);
tumors were larger in cases with conventional epithelial
dysplasia than in those without (mean; 2.1 cm vs. 1.1 cm,
p <0.001). Mean age, sex, and tumor location did not dif-
fer according to the status of conventional epithelial dys-
plasia (p = 0.235, p = 1.000, and p = 0.178, respectively).
In total, 191 CAs were obtained from 188 patients:
105 males and 83 females with a mean age of 62.7 years.
There was no significant difference between patients
with TSA and those with CA with respect to mean age or
sex (p = 0.339 and p = 0.229, respectively). Moreover,
there were no differences in age or sex among patients
with TA, TVA, and VA (p = 0.382 and p = 0.506, respect-
ively). The mean tumor size of CAs was larger than that
of TSAs (2.9 cm vs. 1.3 cm, p <0.001), most likely because
we included CAs obtained by ESD or EMR. Three patients
with CA had a prior history of right-sided SSA/Ps, and 10
other patients with CAs had synchronous or metachro-
nous SSA/P. All 13 cases of SSA/P were histologically
proven. The clinicopathologic features of the patients with
TSA and CA are summarized in Table 2.
Histologic findings
All of the cases of TSA included in this study exhibited
a serrated architecture in at least 20% of the tumor area











30 (45.5%) 2 (10.5%)





62 (93.9%) 19 (100%)
0 0
a; TVA, tubulovillous adenoma; VA, villous adenoma; NA, not applicable; EMR,
Figure 1 Histologic findings of traditional serrated adenoma (TSA). (A), TSA showing a protuberant growth pattern and serrated architecture
(hematoxylin and eosin; original magnification × 40). (B), TSA composed of tall columnar cells with diffuse serration and abundant eosinophilic
cytoplasm. Note the abundant ectopic crypts (hematoxylin and eosin; original magnification × 200).
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power images of TSAs were somewhat variable depend-
ing on the growth pattern, the extent of peculiar tall
columnar cells with eosinophilic cytoplasm, the status
of precursor lesions, and the amount of stromal com-
ponent. ECF was identified in most (79.4%) but not all
cases of TSA (Figure 1B). The frequency of ECF varied de-
pending on the case or even the area within the same case.Figure 2 Conventional adenoma (CA) with a focal villous architecture
conventional dysplasia and focal epithelial serration (hematoxylin and eosi
in panel A, showing dysplastic cells with cytoplasmic eosinophilia and
(C), Tubulovillous adenoma (TVA) with a villous architecture and colum
eosin; original magnification × 100). (D), Higher magnification of the bo
eosin; original magnification × 200).ECF was numerous in 15.0% of cases, whereas some cases
(5.7%) displayed minimal ECF.
ECF was present in 62 (32.5%) cases of CA (Figures 2
and 3). The frequency of ECF in TAs, TVAs, and VAs
was 22.6% (24 cases), 37.9% (25 cases), and 68.4% (13
cases), respectively (p <0.001) (Table 3). ECF was sparse
in all but three cases of CA. Most CAs had ampho-
philic or basophilic cytoplasm, although a minority (5.2%). (A), Tubular adenoma (TA) composed of columnar cells with diffuse
n; original magnification × 40). (B), Higher magnification of the box
ectopic crypts (hematoxylin and eosin; original magnification × 200).
nar cells with diffuse conventional dysplasia (hematoxylin and
x in panel C, displaying ectopic crypts (arrows) (hematoxylin and
Figure 3 Tubulovillous adenoma (TVA) with high grade dysplasia. (A), TVA with a villous architecture and columnar cells showing diffuse
high grade dysplasia (hematoxylin and eosin; original magnification × 40). (B), Box in panel A, displaying high grade dysplasia and ectopic crypts
(hematoxylin and eosin; original magnification × 100).
Table 3 Comparison of histologic features according to








ECF (%) 24 (22.6%) 25 (37.9%) 13 (68.4%) < 0.001
Focal serration (%) 7 (6.6%) 7 (10.6%) 6 (31.6%) 0.005
Focal cytoplasmic
eosinophilia (%)
1 (0.9%) 4 (6.1%) 5 (26.3%) < 0.001
CA, conventional adenoma; ECF, ectopic crypt formation; TA, tubular adenoma;
TVA, tubulovillous adenoma; VA, villous adenoma.
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that was significantly associated with the presence of ECF
(p <0.001) (Figure 2A and B). The presence of ECF sig-
nificantly correlated with the presence of villosity and
large tumor size (each p <0.001; Figure 2C and D).
ECF was also noted in CA with high-grade dysplasia
(HGD) as well as that with low-grade dysplasia (LGD)
(Figure 3A and B). Serration of crypts was noted in
20 (10.5%) cases of CA; however, epithelial serration
accounted for less than 5% of the polyp area in all but
one CA, in which serration of crypts occupied approxi-
mately 20% of the area. In that case, the epithelial
serration was concentrated in the middle and lower
portions of crypts associated with dilatation. Three CA
cases showed Paneth cell metaplasia in areas with ECF
(Figure 4A and B). In 16 CA cases, ECF, focal serration,
and cytoplasmic eosinophilia occurred in the same polyp.
The presence of ECF was significantly associated with
focal serration of crypts and cytoplasmic eosinophilia in
CA (each p <0.001).
Mutation results for BRAF and KRAS genes
BRAF mutation was observed in 59 (55.1%) TSA lesions,
and KRAS mutations were identified in 36 (33.6%) cases.
Mutations of BRAF and KRAS were mutually exclusive.
Twelve (11.2%) TSA lesions showed neither BRAF 600E
nor KRAS codon 12, 13, or 61 mutations. Among three
cases of CA showing significant numbers of ectopic
crypts, two showed KRAS mutation, while the other dis-
played neither BRAF nor KRAS mutation (Figure 5).
Discussion
TSA is a distinct subtype of serrated neoplasm that is
usually characterized by a protuberant growth pattern
with an overall complex and often villous growth pat-
tern, epithelial serration, and tall columnar cells with
abundant eosinophilic cytoplasm and elongated pencillate
nuclei [1-3]. However, the diagnosis of TSA is sometimeschallenging because of overlap with other polyps in terms
of both gross and histologic features. More specifically,
the gross morphology does not distinguish TSAs from
other polyps because TSAs vary from flat elevated and
sessile to pedunculated forms [9]. A pedunculated config-
uration, which is known to be frequent in TSAs, is also
found in other polyps, in particular the so-called ‘pedun-
culated serrated polyp with SSA/P features’ and CA [10].
The former lesion is a newly described serrated polyp that
has clinicopathologic features of SSA/P except for the
pedunculated gross configuration. The complex villous
growth pattern can also be identified in CA. Serration of
crypts can be observed in various conditions such as in-
flammatory bowel disease, juvenile polyps, inflammatory
polyps, and CAs, as well as other kinds of serrated polyps
[11-13]. In addition, the characteristic cytological features
such as abundant eosinophilic cytoplasm and pencillate
nuclei can be found in other serrated polyps such as SSA/
P or sessile serrated adenoma with dysplasia (SSA/D), as
well as in CA [14]. In summary, none of these histopatho-
logic features alone is considered specific for TSA. There-
fore, in this study, we defined TSA as a lesion combining
a serrated architecture and at least one focal area contain-
ing tall columnar cells with elongated nuclei and abundant
eosinophilic cytoplasm [2].
Recently, the presence of ECF has been suggested to be
the best defining histologic feature to diagnose TSA [4,5].
Figure 4 Tubulovillous adenoma (TVA) with ectopic crypts and Paneth cell metaplasia. (A), TVA with frequent ectopic crypts (hematoxylin
and eosin; original magnification × 100). (B), Higher magnification of the box in panel A, displaying ectopic crypts showing Paneth cell metaplasia
(hematoxylin and eosin; original magnification × 200).
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tially suggested to be exclusive to TSA, was reported
to be present in other serrated polyps such as HP or
SSA/P [14]. Similar to the result by Ensari et al. [14],
ECF was noted in approximately 80% of TSA cases in
the present study. In addition, a considerable fraction
of CA showed ECF, albeit most cases were sparse. Al-
though TSA showed a higher frequency of ECF than
CA (p <0.001), the frequency of ECF in CA (32.5%)
was higher than we expected, particularly in cases with a
villous component (p <0.001). The actual rate of ECF, par-
ticularly in polypectomy specimens, might be lower than
that of the present study because we included large CAs
obtained by ESD or EMR. At any rate, ECF itself does not
seem to be a sine qua non for the diagnosis of TSA be-
cause ECF can be found in CA, although its identification
might be very helpful in the diagnosis of TSA. Therefore,
if one encounters colorectal polyps with ECF, the possi-
bility of CA should always be considered. In such cases,Figure 5 Mutational profiling using the Sequenom MassArray platforhistologic evaluation for the presence and/or extent of
crypt serration, extent of ECF, and cytoplasmic character-
istics are necessary to distinguish TSA from CA with ECF
(Figure 6). Absence of extensive ECF, prominent serra-
tion, serrated dysplasia, and/or diffuse cytologic eosino-
philia are histologic features favoring a diagnosis of CA
over TSA. According to the results of this study, the ex-
tent of serration did not exceed 20% of crypts in CA.
In addition to the histopathologic evaluation, the re-
sults of molecular studies for BRAF mutation are also
important in the differentiation of CA from TSA be-
cause BRAF mutation is rare in CA (<1%) but common
in TSA [15-17]. Mutation study for KRAS seems to be less
useful than BRAF testing in the distinction between CA
and TSA, although the frequency of KRAS mutations is
lower in TSA than in CA [17]. In the present study, we
performed mutation study for KRAS and BRAF in order
to investigate whether BRAF mutation was present in CA
with frequent ECF. As expected, none of these casesm. Sequenom MassArray identifying the KRAS 12G > A mutation.
Figure 6 Schematic representation of the diagnosis of polyps showing ectopic crypt formation (ECF).
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CAs with frequent ECF showed KRAS mutations. Muta-
tion study of the APC gene might be also helpful in the
distinction between CA and TSA because, in contrast to
CA, APC gene mutation is infrequent in TSA [18]. How-
ever, we could not perform molecular study of the APC
gene in this study.
The presence of ECF, serration of crypts, and cytoplas-
mic eosinophilia in some CAs suggest the possibility that
such polyps share a series of molecular alterations with
TSAs that are responsible for the histological differenti-
ation toward serrated neoplasia. Accordingly, Pai et al.
[19] reported that a subset of CA shows atypical features
such as cytoplasmic eosinophilia with or without focal
serrations, usually in patients predisposed to developing
SSA/P. On molecular analysis, these atypical CAs showed
a higher frequency of CpG island methylation than did
typical CA (35.7% vs. 4.2%). We did not find any signifi-
cant difference in the rates of ECF, cytoplasmic eosino-
philia, or serration of crypts between CA that developed
SSA/P and CA that did not (p = 0.228, p = 0.515, and p =
1.000, respectively), although this might be because of the
small number of patients that developed SSA/P among
the patients with CA.
We believe that CA with ECF is not uncommon, al-
though there is some controversy over whether such cases
represent TSA with diffuse conventional dysplasia [5].
Indeed, most CAs in this study were otherwise typical,
except for three cases that showed easily recognizable
ECF, none of which showed prominent serration of crypts
(more than 20%), serrated dysplasia, diffuse cytoplasmic
eosinophilia, or BRAF mutation. According to a previous
study, ECF is considered one of the mechanisms that in-
crease crypt numbers as a result of complex biologic pro-
cesses involving a sequential proliferation-differentiation
process that depends on the time point and epithelial-mesenchymal interaction [20]. It is presumed that inhib-
ition of bone morphogenic protein (BMP) signaling results
in the formation of ectopic crypt units perpendicular to
the crypt-villus axis [21]. The concentration of Ki-67+ cells
in ectopic crypts supports our contention that ectopic
crypts play an important role in the protuberant growth of
polyps [4]. Accordingly, the presence of ECF significantly
correlated with large tumor size in this study.
Conclusions
In conclusion, ECF appears to be associated with villous
or protuberant growth of colorectal adenoma. Although
identification of ECF seems to be very helpful in the
diagnosis of TSA, ECF is also found in CA, particularly
in cases with a villous component. Therefore, the possi-
bility of CA should be considered before making a diag-
nosis of TSA in cases of colorectal polyp with ECF.
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